NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

尿液檢查的全球市場 (∼2026年):各產品 (測試棒、妊娠&排卵套件、試劑、拋棄式品、自動/半自動/POC分析設備)、用途 (尿結石、糖尿病、腎臟病)、終端用戶 (醫院、實驗室、居家醫療)、檢驗類型、地區

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type-Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1024375
出版日期 內容資訊 英文 237 Pages
訂單完成後即時交付
價格
尿液檢查的全球市場 (∼2026年):各產品 (測試棒、妊娠&排卵套件、試劑、拋棄式品、自動/半自動/POC分析設備)、用途 (尿結石、糖尿病、腎臟病)、終端用戶 (醫院、實驗室、居家醫療)、檢驗類型、地區 Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type-Global Forecast to 2026
出版日期: 2021年08月17日內容資訊: 英文 237 Pages
簡介

尿液檢查的市場規模在預測期間內預計以7.2%的年複合成長率發展,從2021年的35億美元,成長到2026年49億美元性規模成長。

尿結石,糖尿病,腎臟、肝臟疾病增加,老年人口增加與其伴隨的老齡化性疾病增加,POC診斷檢驗的引進增加等要素促進該市場的成長。同時,可尿分析設備的再生品取得,今後數年預計市場成長一定程度受到限制。

各產品中,預計消耗品的部門在預測期間內顯示最大的成長。各用途中,疾病篩檢的部門顯示最大的年複合成長率。UTI和腎臟疾病的發生率的世界增加促進該部門的成長。

本報告提供全球尿液檢查的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,技術、專利分析,市場規模的變化、預測,產品、檢驗類型、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19的影響
  • 市場成長方案
  • 價格分析
  • 專利分析
  • 貿易分析
  • 價值鏈
  • 生態系統分析
  • 波特的五力分析
  • 法規情形
  • 技術分析
  • 大環境分析
  • 給予客戶企業的影響的趨勢

第6章 市場分析、預測:各產品

  • 消耗品
    • 妊娠、排卵套件
    • 沾醬棒
    • 拋棄式品
    • 試劑
  • 設備
    • 自動尿液分析儀
    • 半自動尿液分析儀
    • 照護現場尿分析設備

第7章 市場分析、預測:各檢驗類型

  • 妊娠、排卵檢驗
  • 生物化學的尿液檢查
    • 實驗室檢驗
    • POC檢驗
  • 尿沈渣檢驗

第8章 市場分析、預測:各用途

  • 疾病篩檢
    • 泌尿道感染
    • 腎臟病
    • 糖尿病
    • 肝疾病
    • 其他
  • 妊娠、排卵

第9章 市場分析、預測:各終端用戶

  • 診斷實驗室
  • 醫院、診所
  • 居家醫療
  • 研究實驗室、機關

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 競爭情形

  • 概要
  • 主要企業的策略
  • 主要企業的收益佔有率分析
  • 市場佔有率分析
  • 企業評估象限
  • 新興企業/中小企業的競爭領導製圖
  • 競爭基準
  • 競爭模式

第12章 企業簡介

  • 主要企業
    • SIEMENS HEALTHINEERS AG
    • F. HOFFMANN-LA ROCHE
    • CARDINAL HEALTH, INC.
    • ABBOTT LABORATORIES
    • DANAHER CORPORATION
    • SYSMEX CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • QUIDEL CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • BIO-RAD LABORATORIES
    • EKF DIAGNOSTICS
  • 其他的主要企業
    • ARKRAY, INC.
    • ACON LABORATORIES, INC.
    • 77 ELEKTRONIKA KFT.
    • URIT MEDICAL ELECTRONIC GROUP CO., LTD.
    • DIRUI INDUSTRIAL CO., LTD.
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • BIOBASE GROUP
    • ERBA MANNHEIM
    • ALPHATECH SCIENTIFIC
    • TECO DIAGNOSTICS
    • ANALYTICON BIOTECHNOLOGIES AG
    • BIOWAY BIOTECHNOLOGY
    • HIGH TECHNOLOGY INC.
    • AGAPPE DIAGNOSTICS LTD.
    • GENRUI BIOTECH INC.
    • SPINREACT S.A.
    • DIALAB GMBH
    • QUANTIMETRIX CORPORATION
    • BIOCARE CORPORATION
    • RANDOX LABORATORIES LTD.
    • PZ CORMAY SA
    • YD DIAGNOSTICS
    • CONTEC MEDICAL SYSTEMS CO., LTD.
    • RAYTO LIFE AND ANALYTICAL SCIENCES CO., LTD.

第13章 附錄

目錄
Product Code: MD 3259

The global urinalysis market size is projected to reach USD 4.9billion by 2026 from USD 3.5billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases and increasing adoption of POC diagnostic tests. On the other hand, availability of refurbished urine analyzersis expected to limit market growth to a certain extent in the coming years.

"The consumablesaccounted for the highest growth rate in theurinalysismarket, byproduct, during the forecast period"

The urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the highest growth rate in the urinalysis market in 2020. The requirement of consumables in large numbers compared to instrumentsis the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of consumables compared to instruments.

"Disease screening segment accounted for the highest CAGR"

Based on the application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In 2020, the disease screening segment accounted for the highest CAGR.The increasing incidence of UTIs and kidney ailments worldwide are driving the growth of this market.

"Diagnostic Laboratoriessegment accounted for the highest CAGR"

Based on end-users, the urinalysismarket is segmented into diagnostic laboratories, hospitals and clinics, home care settings and research laboratories & institutes. In 2020, the diagnostic laboratories segment accounted for the highest CAGR. This can be attributed to rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.

"Asia Pacific: The fastest-growing regionurinalysismarket"

The global urinalysismarket is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such rising geriatric population, high burden of chronic diseases such as CKD, growing per capita income, increasing investments in the healthcare industry by key market players, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinics, and the presence of high-growth markets are driving the growth of the urinalysismarket in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, and Rest of the World - 10%

Lits of Companies Profiled in the Report:

  • Siemens Healthineers AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Cardinal Health, Inc. (US)
  • Abbott Laboratories (US)
  • Danaher Corporation (US)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific Inc. (US)
  • QuidelCorporation(US)
  • Bio-Rad Laboratories, Inc. (US)
  • Becton, Dickinson and Company (US)
  • EKF Diagnostics (UK)
  • ARKRAY, Inc. (Japan)
  • ACON Laboratories, Inc. (US)
  • 77 ElektronikaKft. (Hungary)
  • URIT Medical Electronic Group Co., Ltd. (China)
  • Dirui Industrial Co., Ltd. (China)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • BIOBASE Group (China)
  • ERBA Mannheim (UK)
  • AlphatechScientitfic (Peru)
  • Teco Diagnostics (US)
  • Analyticon Technologies AG (Germany)
  • Bioway Biological Technology Co. Ltd. (China)
  • High Technology Inc. (US)
  • Agappe Diagnostics Ltd. (India)

Research Coverage:

This report provides a detailed picture of the global urinalysismarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user, and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysismarket and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 URINALYSIS MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 URINALYSIS MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Market estimation from the parent market
    • FIGURE 5 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET
      • 2.3.1.3 Approach 3: Presentations of companies and primary interviews
      • 2.3.1.4 Growth rate assumptions
      • 2.3.1.5 CAGR projections
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 7 URINALYSIS MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • 2.7 COVID-19 HEALTH ASSESSMENT
  • 2.8 COVID-19 ECONOMIC ASSESSMENT
  • 2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE URINALYSIS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 URINALYSIS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 URINALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 URINALYSIS MARKET OVERVIEW
    • FIGURE 16 THE RISING ADOPTION OF POC DIAGNOSTICS IS A KEY FACTOR EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
  • 4.2 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 CONSUMABLES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021
  • 4.3 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 18 DISEASE SCREENING TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
  • 4.4 URINALYSIS MARKET, BY REGION, 2021 VS. 2026
    • FIGURE 19 NORTH AMERICA TO DOMINATE THE MARKET IN 2021

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases
      • 5.2.1.2 Rising geriatric population and the subsequent increase in age-associated diseases
    • TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION BY REGION (2019-2050)
      • 5.2.1.3 Increasing adoption of POC urine diagnostic tests
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of refurbished urine analyzers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies
      • 5.2.3.2 Technological advancements in urine analyzers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Changing regulatory landscape for the urinalysis market
  • 5.3 IMPACT OF COVID-19 ON THE URINALYSIS MARKET
  • 5.4 REALISTIC, PESSIMISTIC, AND OPTIMISTIC SCENARIOS
    • 5.4.1 URINALYSIS MARKET
    • FIGURE 21 REALISTIC SCENARIO
    • FIGURE 22 PESSIMISTIC SCENARIO
    • FIGURE 23 OPTIMISTIC SCENARIO
  • 5.5 PRICING ANALYSIS
    • TABLE 3 PRICE OF URINALYSIS PRODUCTS (2021)
  • 5.6 PATENT ANALYSIS
    • 5.6.1 PATENT ANALYSIS OF URINALYSIS PRODUCTS
    • 5.6.2 PATENT ANALYSIS OF DIPSTICKS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
      • 5.7.1.1 Import data for diagnostic and laboratory reagents, by country, 2016 - 2020 (USD Million)
      • 5.7.1.2 Import data for diagnostic and laboratory reagents, by country, 2016 - 2020 (Tons)
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
    • FIGURE 25 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.9 ECOSYSTEM ANALYSIS OF THE URINALYSIS MARKET
    • FIGURE 26 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
    • 5.9.1 ROLE IN ECOSYSTEM
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 URINALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF BUYERS
    • 5.10.4 BARGAINING POWER OF SUPPLIERS
    • 5.10.5 DEGREE OF COMPETITION
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 NORTH AMERICA
      • 5.11.1.1 US
      • 5.11.1.2 Canada
    • 5.11.2 EUROPE
    • 5.11.3 ASIA PACIFIC
      • 5.11.3.1 China
      • 5.11.3.2 Japan
      • 5.11.3.3 India
    • 5.11.4 LATIN AMERICA
      • 5.11.4.1 Brazil
      • 5.11.4.2 MEXICO
    • 5.11.5 MIDDLE EAST
    • 5.11.6 AFRICA
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 PESTLE ANALYSIS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
    • 5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS PRODUCT MANUFACTURERS
    • 5.14.2 REVENUE SHIFT FOR THE URINALYSIS MARKET

6 URINALYSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 6 URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 6.2 CONSUMABLES
    • 6.2.1 PRIMARY NOTES
      • 6.2.1.1 Key industry insights
    • TABLE 7 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 8 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 9 URINALYSIS CONSUMABLES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 10 URINALYSIS CONSUMABLES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.2 PREGNANCY & FERTILITY KITS
      • 6.2.2.1 Need for rapid pregnancy testing to drive the growth of this market
    • TABLE 11 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 12 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.3 DIPSTICKS
      • 6.2.3.1 Dipsticks are used regularly owing to low costs and standard efficiency
    • TABLE 13 URINALYSIS DIPSTICKS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 14 URINALYSIS DIPSTICKS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.4 DISPOSABLES
      • 6.2.4.1 The wide usage of urine collection cups will drive the market demand for disposables
    • TABLE 15 URINALYSIS DISPOSABLES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 16 URINALYSIS DISPOSABLES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.2.5 REAGENTS
      • 6.2.5.1 Increasing use of controls & calibrators to drive the market growth for reagents
    • TABLE 17 URINALYSIS REAGENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 18 URINALYSIS REAGENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 19 KEY PRODUCTS IN THE INSTRUMENTS MARKET
    • TABLE 20 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 21 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 22 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 23 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.1 AUTOMATED URINE ANALYZERS
      • 6.3.1.1 Increasing need for automation for shorter turnaround times to drive the market growth for automated urine analyzers
    • TABLE 24 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 25 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 26 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 27 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
      • 6.3.1.2 Integrated urine analyzers
        • 6.3.1.2.1 The higher workload in hospitals and laboratories to drive the adoption of integrated urine analyzers
    • TABLE 28 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 29 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
      • 6.3.1.3 Sediment urine analyzers
        • 6.3.1.3.1 Automated sediment urine analyzers increase the productivity of laboratories and integrate patient data for easy access
    • TABLE 30 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 31 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 32 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 33 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
        • 6.3.1.3.2 Microscopy analyzers
  • 6.3.1.3.2.1 Increased adoption of automated microscopy analyzers to drive the market growth of this segment
    • TABLE 34 MICROSCOPY ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 35 MICROSCOPY ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
        • 6.3.1.3.3 Flow cytometry analyzers
  • 6.3.1.3.3.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers
    • TABLE 36 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 37 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
      • 6.3.1.4 Biochemical urine analyzers
        • 6.3.1.4.1 Increasing incidence of kidney diseases & UTIs to increase the adoption of automated biochemical analyzers
    • TABLE 38 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 39 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.2 SEMI-AUTOMATED URINE ANALYZERS
      • 6.3.2.1 Semi-automated urine analyzers are used extensively in hospitals & clinics due to lower costs and practical efficiency
    • TABLE 40 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 41 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.3 POINT-OF-CARE URINE ANALYZERS
      • 6.3.3.1 The need for rapid testing to drive the demand for POC urine analyzers
    • TABLE 42 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 43 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)

7 URINALYSIS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 44 URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 45 URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
  • 7.2 PREGNANCY & FERTILITY TESTS
    • 7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 46 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 47 PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 BIOCHEMICAL URINALYSIS
    • TABLE 48 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 49 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 50 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 51 BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 7.3.1 LABORATORY TESTS
      • 7.3.1.1 Laboratory tests use automated or semi-automated analyzers
    • TABLE 52 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 53 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020-2026 (USD MILLION)
    • 7.3.2 POC TESTS
      • 7.3.2.1 The convenience of POC testing drives the growth of this segment
    • TABLE 54 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 55 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020-2026 (USD MILLION)
  • 7.4 SEDIMENT URINALYSIS
    • 7.4.1 THE INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 56 SEDIMENT URINALYSIS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 57 SEDIMENT URINALYSIS MARKET, BY REGION, 2020-2026 (USD MILLION)

8 URINALYSIS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 58 URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 59 URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 8.2 DISEASE SCREENING
    • TABLE 60 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 61 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 62 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 63 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020-2026 (USD MILLION)
    • 8.2.1 URINARY TRACT INFECTIONS
      • 8.2.1.1 Increasing prevalence of UTIs to drive the growth of this application segment
    • TABLE 64 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 65 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020-2026 (USD MILLION)
    • 8.2.2 KIDNEY DISEASES
      • 8.2.2.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of kidney diseases to drive the market growth
    • TABLE 66 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 67 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020-2026 (USD MILLION)
    • 8.2.3 DIABETES
      • 8.2.3.1 Development of advanced analytical tools for diabetes to drive the market growth
    • TABLE 68 URINALYSIS MARKET FOR DIABETES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 69 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020-2026 (USD MILLION)
    • 8.2.4 LIVER DISEASES
      • 8.2.4.1 The high prevalence of liver diseases increases the demand for urinalysis testing
    • TABLE 70 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 71 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020-2026 (USD MILLION)
    • 8.2.5 OTHER DISEASE SCREENING APPLICATIONS
    • TABLE 72 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 73 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 PREGNANCY AND FERTILITY
    • 8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 74 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 75 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2020-2026 (USD MILLION)

9 URINALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 76 URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 77 URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • TABLE 78 URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
    • TABLE 79 URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
    • TABLE 80 URINALYSIS END USER MARKET, BY TEST TYPE, 2018 (USD MILLION)
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO LABORATORIES FOR REDUCED COSTS DRIVES THE MARKET GROWTH
    • TABLE 81 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 82 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020-2026 (USD MILLION)
  • 9.3 HOSPITALS AND CLINICS
    • 9.3.1 THE INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE THE MARKET GROWTH FOR THIS END-USER SEGMENT
    • TABLE 83 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 84 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2026 (USD MILLION)
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO DRIVE THE GROWTH OF THIS MARKET
    • TABLE 85 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 86 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2026 (USD MILLION)
  • 9.5 RESEARCH LABORATORIES & INSTITUTES
    • 9.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO DRIVE THE MARKET GROWTH
    • TABLE 87 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 88 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020-2026 (USD MILLION)

10 URINALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 89 URINALYSIS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 90 URINALYSIS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 92 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 94 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • TABLE 95 NORTH AMERICA: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
    • TABLE 96 NORTH AMERICA: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The US dominated the North American urinalysis market in 2020
    • TABLE 97 US: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 98 US: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 99 US: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 100 US: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 101 US: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 102 US: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 103 US: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 104 US: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 The increasing prevalence of chronic conditions like liver diseases in Canada drives the market growth
    • TABLE 105 CANADA: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 106 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 107 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 108 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 109 CANADA: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 110 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 111 CANADA: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 112 CANADA: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 113 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 114 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 115 EUROPE: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 116 EUROPE: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • TABLE 117 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
    • TABLE 118 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing healthcare expenditure to drive the market growth in Germany
    • TABLE 119 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 120 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 121 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 122 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 123 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 124 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 125 GERMANY: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 126 GERMANY: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising government healthcare expenditure propels market growth in the UK
    • TABLE 127 UK: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 128 UK: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 129 UK: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 130 UK: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 131 UK: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 132 UK: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 133 UK: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 134 UK: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising R&D expenditure in France to drive the market growth
    • TABLE 135 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 136 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 137 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 138 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 139 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 140 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 141 FRANCE: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 142 FRANCE: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Age-related chronic kidney disease owing to a large senior population in Italy to drive the market growth for urinalysis
    • TABLE 143 ITALY: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 144 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 145 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 146 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 147 ITALY: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 148 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 149 ITALY: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 150 ITALY: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 The rising geriatric population in Spain is expected to drive the market growth
    • TABLE 151 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 152 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 153 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 154 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 155 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 156 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 157 SPAIN: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 158 SPAIN: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 159 ROE: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 160 ROE: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 161 ROE: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 162 ROE: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 163 ROE: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 164 ROE: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 165 ROE: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 166 ROE: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 28 APAC: URINALYSIS MARKET SNAPSHOT
    • TABLE 167 APAC: URINALYSIS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 168 APAC: URINALYSIS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 169 APAC: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 170 APAC: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • TABLE 171 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
    • TABLE 172 APAC: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Improving healthcare infrastructure in China supports the growth of the urinalysis market
    • TABLE 173 CHINA: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 174 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 175 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 176 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 177 CHINA: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 178 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 179 CHINA: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 180 CHINA: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.2 INDIA
      • 10.4.2.1 Increasing private & public investments in India's healthcare system to drive the market growth for urinalysis testing
    • TABLE 181 INDIA: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 182 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 183 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 184 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 185 INDIA: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 186 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 187 INDIA: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 188 INDIA: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Favorable regulatory framework to drive the market growth in Japan
    • TABLE 189 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 190 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 191 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 192 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 193 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 194 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 195 JAPAN: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 196 JAPAN: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 197 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 198 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 199 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2016-2019 (USD MILLION)
    • TABLE 200 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2020-2026 (USD MILLION)
    • TABLE 201 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 202 ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 203 ROAPAC: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 204 ROAPAC: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • 10.5.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE THE HEALTHCARE INFRASTRUCTURE IN THE REGION TO DRIVE THE MARKET GROWTH FOR URINALYSIS PRODUCTS
    • TABLE 205 ROW: URINALYSIS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 206 ROW: URINALYSIS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • TABLE 207 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
    • TABLE 208 ROW: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE URINALYSIS MARKET
    • TABLE 209 OVERVIEW OF STRATEGIES DEPLOYED BY KEY URINALYSIS PRODUCT MANUFACTURING COMPANIES
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE URINALYSIS MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 30 URINALYSIS MARKET SHARE, BY KEY PLAYER (2020)
    • TABLE 210 URINALYSIS MARKET: DEGREE OF COMPETITION
    • 11.4.1 URINALYSIS MARKET RANKING, BY TEST TYPE
      • 11.4.1.1 Biochemical urinalysis
    • TABLE 211 GLOBAL BIOCHEMICAL URINALYSIS MARKET, BY KEY PLAYERS, 2020
      • 11.4.1.2 Sediment urinalysis
    • TABLE 212 GLOBAL SEDIMENT URINALYSIS MARKET, BY KEY PLAYERS, 2020
      • 11.4.1.3 Pregnancy & fertility tests
    • TABLE 213 GLOBAL PREGNANCY & FERTILITY TESTS MARKET, BY KEY PLAYERS, 2020
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 LIST OF EVALUATED VENDORS
    • 11.5.2 STARS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PERVASIVE PLAYERS
    • 11.5.5 PARTICIPANTS
    • FIGURE 31 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 32 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
  • 11.7 COMPETITIVE BENCHMARKING
    • FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE URINALYSIS MARKET
    • TABLE 214 COMPANY PRODUCT TYPE FOOTPRINT
    • TABLE 215 COMPANY GEOGRAPHICAL FOOTPRINT
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES AND REGULATORY APPROVALS
    • TABLE 216 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
    • 11.8.2 DEALS
    • TABLE 217 KEY DEALS
    • 11.8.3 URINALYSIS: OTHER DEVELOPMENTS
    • TABLE 218 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 SIEMENS HEALTHINEERS AG
    • TABLE 219 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
    • FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
    • 12.1.2 F. HOFFMANN-LA ROCHE
    • TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
    • FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
    • 12.1.3 CARDINAL HEALTH, INC.
    • TABLE 221 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.4 ABBOTT LABORATORIES
    • TABLE 222 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 37 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 12.1.5 DANAHER CORPORATION
    • TABLE 223 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.6 SYSMEX CORPORATION
    • TABLE 224 SYSMEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.7 THERMO FISHER SCIENTIFIC INC.
    • TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
    • 12.1.8 QUIDEL CORPORATION
    • TABLE 226 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.9 BECTON, DICKINSON AND COMPANY
    • TABLE 227 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 12.1.10 BIO-RAD LABORATORIES
    • TABLE 228 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 43 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
    • 12.1.11 EKF DIAGNOSTICS
    • TABLE 229 EKF DIAGNOSTICS: BUSINESS OVERVIEW
    • FIGURE 44 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2020)
  • 12.2 OTHER PLAYERS
    • 12.2.1 ARKRAY, INC.
    • 12.2.2 ACON LABORATORIES, INC.
    • 12.2.3 77 ELEKTRONIKA KFT.
    • 12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
    • 12.2.5 DIRUI INDUSTRIAL CO., LTD.
    • 12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 12.2.7 BIOBASE GROUP
    • 12.2.8 ERBA MANNHEIM
    • 12.2.9 ALPHATECH SCIENTIFIC
    • 12.2.10 TECO DIAGNOSTICS
    • 12.2.11 ANALYTICON BIOTECHNOLOGIES AG
    • 12.2.12 BIOWAY BIOTECHNOLOGY
    • 12.2.13 HIGH TECHNOLOGY INC.
    • 12.2.14 AGAPPE DIAGNOSTICS LTD.
    • 12.2.15 GENRUI BIOTECH INC.
    • 12.2.16 SPINREACT S.A.
    • 12.2.17 DIALAB GMBH
    • 12.2.18 QUANTIMETRIX CORPORATION
    • 12.2.19 BIOCARE CORPORATION
    • 12.2.20 RANDOX LABORATORIES LTD.
    • 12.2.21 PZ CORMAY SA
    • 12.2.22 YD DIAGNOSTICS
    • 12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
    • 12.2.24 RAYTO LIFE AND ANALYTICAL SCIENCES CO., LTD.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS